Introduction In this pilot study the effects of vitrectomy on PO 2 in the vitreous cavity in CRVO were investigated. Study design Prospective, controlled, interventional study. Method Six patients with ischaemic CRVO in one eye (undergoing vitrectomy for radial optic neurotomy, RON) and six with either macula hole or membrane were included. An oxygen probe was inserted before removal of the vitreous (pre-vitrectomy) and after removal of the vitreous (post-vitrectomy). In the patients with CRVO, measurements were taken before RON was performed. Oxygenation recordings (PO 2 ) were taken in the midvitreous cavity and the preretinal vitreous. Results Mean age was 65 years. In controls, pre-vitrectomy, the mean PO 2 adjacent to the retina (15.0 mmHg S.D.5.7) was significantly less than mid-cavity (33.7 mmHg S. D.12.8). Similarly in CRVO, the pre-vitrectomy pre-retinal PO 2 (8.1 mmHg S.D. 3.5), was significantly less than midcavity (19.8 mmHg S.D.7.3). The mean PO 2 was significantly less in the eyes with CRVO than in control eyes. Post-vitrectomy, the PO 2 was significantly greater than previtrectomy at both recording sites in the controls mid-cavity (61.5 mmHg S.D.13.9) and pre-retinal (75.8 mmHg S.D. 9.1), and CRVO eyes mid-cavity (53.7 mmHg S.D. 17.9) and pre-retinal (59.8 mmHg S.D. 15.8).
Introduction
Central retinal vein occlusion (CRVO) is the most frequent vascular cause of visual loss [1] after diabetic retinopathy, but the exact pathogenesis is unknown [2] . The central retinal vein appears to reduce in calibre as it passes through the lamina cribrosa [3] , which may predispose the vein to occlusion. If the occlusion is minor, retinal ischaemia is limited, but more severe CRVO manifests as a more ischaemic type. Ischaemic retinal damage enhances production of vascular endothelial growth factor (VEGF) in the vitreous cavity [4] , which in turn stimulates neovascularization of the posterior and anterior segment and is responsible for potentially devastating secondary complications such as neovascular glaucoma. In addition, VEGF promotes vascular permeability, causing cystoid macular oedema.
Several treatments have been proposed, including injections of recombinant tissue plasminogen activator into the vitreous, or direct injection into a cannulated central vein [5] and intravitreal injection of steroid [6] or anti-VEGF agents [7, 8] . A surgical method in recent years has been radial optic neurotomy (RON) [9] , thought to be effective as a result of improving central retinal vein blood flow by relieving pressure on the vein as it exits the lamina cribrosa. In combination with pars plana vitrectomy (PPV), good anatomical and visual results in patients with non-ischaemic and ischaemic CRVO have been claimed [10] . However, the effects of the vitrectomy on the condition have not been elucidated; for example, PPV may be useful in CRVO because of increased oxygenation to the retina [11] . We hypothesise that vitreous PO 2 measured in patients with CRVO is reduced compared to control, and this hypoxia may be reversed post-vitrectomy by replacement of the vitreous humour with a physiological saline solution.
Method
The study was undertaken with approval from the local Ethics Committee with informed patient consent, and was performed in accordance with the Helsinki declaration. Six patients with ischaemic CRVO in one eye who were to receive PPV and RON were recruited into the study. None had iris neovascularisation at the time of operation, and cystoid macular oedema was not formally investigated. As controls, six patients with either macula hole or epiretinal membrane removal undergoing vitrectomy were used. The affected eye was dilated using a mixture of phenylephrine 2.5% and tropicamide 1%. Three sclerotomies were prepared. The infusion cannula was inserted but not switched on.
Flexible Licox oxygen electrodes were used in combination with an AC3.1 monitor (Integra Neurosciences). The oxygen probe was first calibrated, and readings taken in balanced salt solution (BSS) at room temperature for reference. The oxygen probe was inserted, and oxygenation recordings were taken in the mid-vitreous cavity and preretinal vitreous inferior to the disc and away from visible blood vessels. Each new position required 3-4 minutes for the probe measurements to equilibrate. Values of pulse, blood pressure and arterial oxygen saturation were also taken.
After the first readings, a standard three-port pars plana vitrectomy was performed in which the posterior hyaloid was detached and removed if required. A second set of oxygenation recordings were taken post-vitrectomy. RON was performed in a radial fashion (to avoid transecting the nerve fibres) in the nasal optic disc in the patients with CRVO after any readings were obtained. A specificallydesigned micro vitreoretinal (MVR) blade was inserted to a depth of 2.5 mm, as described previously [9] . If bleeding was observed, the infusion bottle was raised to stop the haemorrhage. The eyes in control patients underwent standard epiretinal membrane removal or macula hole surgery. Phacoemulsification was performed before vitrectomy if required. Post-operative follow up was conducted at 2, 4, 8 and 16 weeks. Data are quoted as mean and standard deviation. Paired or unpaired Student's t-tests were used to examine differences between data sets. The null hypothesis was rejected at p<0.05.
Results
Data were obtained from six control patients (five males, one female) and six with CRVO (one male, five females), and are shown in Table 1 . In one patient from each group, measurements were made only in the middle of the vitreous humour cavity, whereas in the remainder additional measurements were made adjacent to the retina. The ages of the patients ranged from 46 to 82 years of age with a mean of 65 years, with no difference in the mean age of the two groups. The time interval of CRVO diagnosis to treatment was 2 to 12 months, with a mean of 8 months. With all patients, the postoperative follow-up period ranged from 3 to 12 months, with a mean of 7 months. The median preoperative best-corrected visual acuity (BCVA) was 6/60 for control eyes and counting fingers (CF) for study eyes. The median postoperative BCVA was 6/12 for control eyes and CF for study eyes. None of the eyes suffered retinal or iris neovascularisation within the follow-up period. Values were recorded at two sites, mid-cavity and pre-retina, before and after vitrectomy and replacement of vitreous humour with balanced salt solution. Shown also are values for mean arterial blood pressure (MABP) and heart rate (HR) as noted when PO 2 recordings were made. * pre-retina vs mid-cavity (Student's paired t-test); § CRVO vs control (Student's unpaired t-test); both p<0.05. Data are mean ± SD.
Systemic measurements
In all patients, peripheral O 2 saturation was more than 98% throughout. There were no differences in mean arterial blood pressure (MAPD) or heart rate (HR) between controls (MAPD 81. 
Ocular measurements
In control eyes, pre-vitrectomy, the mean PO 2 adjacent to the retina (pre-retina) was significantly less than in midcavity; see Table 1 . Figure 1a shows that in all five eyes in which paired results were obtained, there was a PO 2 gradient in the same direction between the two sites: the mean difference was 18.0±16.0 mmHg. In some eyes the gradient was substantial, whereas in others it was small. In the CRVO eyes, a similar PO 2 gradient was recorded previtrectomy. Furthermore, at both recording sites the mean PO 2 was significantly less than in the eyes with CRVO, compared to control eyes; Fig. 1a , Table 1 . In three patients (one control, two CRVO), PO 2 measurements were also taken immediately behind the lens. The values were not different from those in the mid-cavity, and were not recorded in subsequent experiments so as to minimise the duration of the experimental procedure. Post-vitrectomy, the PO 2 was significantly greater than pre-vitrectomy at both recording sites in the control and CRVO eyes. Furthermore, the negative gradient of PO 2 between the mid-cavity and pre-retinal sites was abolished in both groups; in the control group, there was even a small reversed PO 2 gradient (i.e. pre-retinal PO 2 >mid-cavity PO 2 ), whilst in the CRVO group there was no significant gradient. The results are summarised in Fig. 1b and Table 1 .
Discussion
Intravitreal oxygen has not been measured previously in patients with CRVO. In this pilot study, the PO 2 in the vitreous was reduced in eyes with CRVO compared to controls. This reflects the reduction in blood supply to the retina in these patients as detected on fluorescein angiography and Doppler studies [12] . However, it is surprising that the relatively small proportion of ocular blood supply which is directed to the retina (2-3% of total ocular blood flow) [13] has such a profound effect on the vitreal PO 2 . Examinations of other conditions with retinal ischaemia, namely diabetic retinopathy, have also shown reductions in vitreal PO 2 [14] [15] [16] [17] [18] [19] [20] .
The vitreous is in contact with the retina, ciliary body, lens and aqueous. All may provide diffusion of oxygen molecules onto the vitreous. In animal models, the PO 2 is lower in the anterior vitreous (just posterior to the lens) than in the posterior vitreous, although it increases again when very close to the retinal surface [21, 22] . In humans the PO 2 gradient is reversed, with reduced PO 2 in the posterior vitreous [18] , a finding confirmed in our study both in CRVO and controls. Gradients such as this would not be expected in tissues with free movement of oxygen in the vitreous, and therefore there appears to be some resistance to oxygen diffusion in the vitreous which causes a gradient to appear. It has been suggested that the reduced diffusion of oxygen in the vitreous is to protect the crystalline lens from oxidation, in order to maintain its clarity [14] . Indeed, removal of the vitreous is associated with early production of nuclear sclerotic cataract in most individuals, except interestingly those with evidence of ischaemia, such as those with diabetic retinopathy.
We found increased PO 2 in the vitreous cavity preoperatively after removal of the vitreous; however, it is likely that the infusion fluid possesses increased PO 2 from its exposure to atmospheric oxygen bubbled into the infusion bottle. Therefore, the results are unlikely to be representative of the PO 2 expected postoperatively. It was, however, interesting to note a lack of gradient in the fluid filled vitreal cavity, suggesting a reduced barrier to oxygen diffusion in these patients. The elimination of gradients in the vitreal cavity after PPV has also been shown in diabetic retinopathy [16] .
In animal studies, removal of the vitreous has resulted in increased PO 2 measurements in the vitreal cavity, possibly from diffusion of oxygen from other parts of the eye with high blood flow such as the ciliary body or the choroid. In addition, the removal of the vitreous may facilitate diffusion of oxygen from the anterior segment of the eye, where oxygen diffuses through the cornea [23] . The increase in PO 2 is maintained for weeks after the vitrectomy [22] . In humans who have previously had PPV, increased PO 2 levels have been recorded compared with patients with vitreous in situ [24] . Vitrectomy has therefore been suggested as therapy for ischaemic conditions in the eye, particularly in the retina. For example, this has been suggested as a potential mechanism for the improved prognosis for diabetic retinopathy after vitrectomy [25] .
Opremcak has claimed improved results for visual recovery in patients with CRVO and RON [9, 26] . However, it is possible that any improvements in the condition are due to the effects of the PPV on oxygenation rather than decompression of the central retinal vein by RON [11] . Indeed, in an animal model RON has been shown to cause swelling of the optic nerve head, which might increase pressure on the vein in the short term [27] . This has been detected in a Doppler study of the blood flow in the optic nerve head (optic nerve head throttle), which showed an increase in velocities in the lamina cribrosa in some patients after RON [3] .
The numbers of patients were too small to analyze the relationship of intravitreal PO 2 and other surrogate measures of retinal ischaemia such as fluorescein angiography. However, the finding of reduced PO 2 reinforces the need to find a way of improving oxygenation in these patients. A number of techniques are available which could be utilized. Hyperbaric oxygen breathing increases retinal and vitreal PO 2 in animals [28] , and has been tried in retinal vein occlusion [29] . This method could be used overnight when dark adaptation increases oxygen consumption [28] . Perfusion of the vitreous cavity with oxygen-rich fluids (either balanced salt solution or perfluorocarbon liquids) may protect the retina from ischaemia [30, 31] . The reduction in PO 2 suggests that relative barriers to oxygen transport, such as silicone oil, should be avoided in these patients [32] .
In conclusion, this pilot study has demonstrated reduced PO 2 measurements in the vitreous cavity of patients with CRVO. Vitrectomy may be useful in increasing the PO 2 , thereby potentially improving oxygenation to the retina. The reduction of PO 2 suggests a need to investigate ways of increasing oxygen availability to the retina.
